MSGSX | VSGAX | MSGSX / VSGAX | |
Total Expense Ratio | 0.95 | 0.07 | 1,357% |
Annual Report Gross Expense Ratio | 0.95 | 0.07 | 1,357% |
Fund Existence | 26 years | 14 years | - |
Gain YTD | 3.898 | 4.401 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 548M | 37.5B | 1% |
Annual Yield % from dividends | 0.00 | 0.53 | - |
Returns for 1 year | 2.59 | 11.42 | 23% |
Returns for 3 years | 24.03 | 33.30 | 72% |
Returns for 5 years | -0.37 | 35.40 | -1% |
Returns for 10 years | 4.10 | 136.91 | 3% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XCNY | 26.45 | -0.09 | -0.33% |
SPDR S&P Emerging Markets ex-China ETF | |||
PID | 21.37 | -0.13 | -0.62% |
Invesco International Div Achiev ETF | |||
HRTS | 29.18 | -0.50 | -1.68% |
Tema Heart & Health ETF | |||
PBE | 67.58 | -1.26 | -1.83% |
Invesco Biotechnology & Genome ETF | |||
IBIT | 62.88 | -3.37 | -5.09% |
iShares Bitcoin Trust ETF |